Scott Powell | Executive Vice President of Investor Relations |
Cameron Reynolds | President and Chief Executive Officer |
Terig Hughes | Chief Financial Officer |
Thomas Butera | Chief Executive Officer of Volition Veterinary Diagnostics Development |
Bruce Jackson | Benchmark Company |
Nathan Weinstein | Aegis Capital |
Steven Ralston | Zacks Investment Research |
Michael Okunewitch | Maxim Group |
Hello, and welcome to VolitionRx Limited Second Quarter 2021 Financial Results and Business Update Conference Call and Webcast. At this time, all participants are in listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to Scott Powell, Executive Vice President, Investor Relations.